| Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort JA Kolberg, T Jørgensen, RW Gerwien, S Hamren, MP McKenna, E Moler, ... Diabetes care 32 (7), 1207-1212, 2009 | 195 | 2009 |
| CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo AN Tse, KG Rendahl, T Sheikh, H Cheema, K Aardalen, M Embry, S Ma, ... Clinical cancer research 13 (2), 591-602, 2007 | 171 | 2007 |
| Analysis of molecular profile data using generative and discriminative methods EJ Moler, ML Chow, IS Mian Physiological genomics 4 (2), 109-126, 2000 | 158 | 2000 |
| Identifying marker genes in transcription profiling data using a mixture of feature relevance experts ML Chow, EJ Moler, IS Mian Physiological genomics 5 (2), 99-111, 2001 | 133 | 2001 |
| Analysis of the and bands of the x-ray absorption spectrum of amorphous carbon J Díaz, S Anders, X Zhou, EJ Moler, SA Kellar, Z Hussain Physical Review B 64 (12), 125204, 2001 | 93 | 2001 |
| Novel compositions and methods in cancer A Lai, A Fanidi, R Booher, G Yu, E Moler, M Rowe US Patent App. 11/403,116, 2007 | 91 | 2007 |
| Methods for use with nanoreactors MS Urdea, TM Tarasow, EJ Moler US Patent App. 12/436,585, 2010 | 90 | 2010 |
| Gene products differentially expressed in cancerous cells VW Chan, J Escobedo, PD Garcia, R Hansen, J Kaufmann, GC Kennedy, ... US Patent 7,700,359, 2010 | 74 | 2010 |
| Effects of inhibitors of FGFR3 on gene transcription C Heise, E Masih-Khan, E Moler, M Rowe, K Stewart, S Trudel US Patent 8,158,360, 2012 | 68 | 2012 |
| Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes GA Nichols, EJ Moler Metabolic syndrome and related disorders 9 (2), 127-133, 2011 | 68 | 2011 |
| Integrating naive Bayes models and external knowledge to examine copper and iron homeostasis in S. cerevisiae EJ Moler, DC Radisky, IS Mian Physiological Genomics 4 (2), 127-135, 2000 | 53 | 2000 |
| Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes GA Nichols, EJ Moler Diabetologia 54, 523-526, 2011 | 51 | 2011 |
| Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99) M Urdea, J Kolberg, J Wilber, R Gerwien, E Moler, M Rowe, P Jorgensen, ... Journal of diabetes science and technology 3 (4), 748-755, 2009 | 51 | 2009 |
| Near-edge sodium and fluorine K-shell photoabsorption of alkali halides E Hudson, E Moler, Y Zheng, S Kellar, P Heimann, Z Hussain, DA Shirley Physical Review B 49 (6), 3701, 1994 | 47 | 1994 |
| Structural determination of p2mg(2×1)CO/Ni(110) with the use of angle-resolved photoemission extended fine structure Z Huang, Z Hussain, WT Huff, EJ Moler, DA Shirley Physical Review B 48 (3), 1696, 1993 | 44 | 1993 |
| Spatial structure determination of (√3×√3)R30° and (1.5×1.5)R18° CO or Cu(111) using angle-resolved photoemission extended fine structure EJ Moler, SA Kellar, WRA Huff, Z Hussain, Y Chen, DA Shirley Physical Review B 54 (15), 10862, 1996 | 40 | 1996 |
| Cost-effectiveness of risk stratification for preventing type 2 diabetes using a multi-marker diabetes risk score SD Sullivan, LP Garrison Jr, H Rinde, J Kolberg, EJ Moler Journal of medical economics 14 (5), 609-616, 2011 | 34 | 2011 |
| Diabetes incidence for all possible combinations of metabolic syndrome components GA Nichols, EJ Moler Diabetes Research and Clinical Practice 90 (1), 115-121, 2010 | 33 | 2010 |
| Toward a soft X-ray Fourier-transform spectrometer MR Howells, K Frank, Z Hussain, EJ Moler, T Reich, D Möller, DA Shirley Nuclear Instruments and Methods in Physics Research Section A: Accelerators …, 1994 | 33 | 1994 |
| SEMA4D in cancer diagnosis, detection and treatment A Lai, A Fanidi, R Booher, C Tse, X Xu, G Yu, E Moler, M Rowe US Patent 7,919,246, 2011 | 27 | 2011 |
